Original Research
Published on 11 Nov 2025
Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations
in Cancer Immunity and Immunotherapy
- 466 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Published on 11 Nov 2025
in Inflammation
Case Report
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Brief Research Report
Published on 11 Nov 2025
in Higher Education
Case Report
Published on 11 Nov 2025
in Pediatric Urology
Original Research
Published on 11 Nov 2025
in Food Chemistry
Policy and Practice Reviews
Published on 11 Nov 2025
in Life-Course Epidemiology and Social Inequalities in Health
Opinion
Published on 11 Nov 2025
in Cancer Genetics
Review
Published on 11 Nov 2025
in Mucosal Immunity
Original Research
Published on 11 Nov 2025
in Biomaterials
Correction
Published on 11 Nov 2025
in Coronary Artery Disease
Systematic Review
Published on 11 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 11 Nov 2025
in AI in Finance
Perspective
Published on 11 Nov 2025
in Digital Mental Health
Review
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 11 Nov 2025
in Translational and Clinical Endocrinology